HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas P Franks Selected Research

Krypton

11/2019Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms.
11/2013Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas P Franks Research Topics

Disease

7Traumatic Brain Injuries (Traumatic Brain Injury)
11/2020 - 02/2008
5Hypothermia
10/2019 - 08/2005
5Brain Injuries (Brain Injury)
11/2013 - 06/2002
4Hypoxia (Hypoxemia)
11/2019 - 01/2005
4Wounds and Injuries (Trauma)
11/2019 - 02/2008
4Asphyxia (Suffocation)
01/2016 - 10/2004
3Sleep Deprivation
01/2022 - 04/2015
3Unconsciousness (Loss of Consciousness)
10/2014 - 02/2011
3Infarction (Infarctions)
12/2012 - 02/2006
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 11/2016
2Mania (Manias)
01/2021 - 01/2021
2Neuroinflammatory Diseases
11/2020 - 01/2019
2Acidosis
01/2016 - 01/2005
2Brain Ischemia (Cerebral Ischemia)
12/2012 - 10/2003
1Mental Disorders (Mental Disorder)
01/2021
1Gliosis
01/2019
1Memory Disorders (Memory Loss)
01/2019
1Narcolepsy
01/2019
1Cataplexy
01/2019
1Sleepiness
01/2019
1Reinjuries
01/2018
1Delirium
01/2018
1Shock
01/2018
1Movement Disorders (Movement Disorder)
11/2016
1Seizures (Absence Seizure)
01/2016
1Brain Diseases (Brain Disorder)
01/2016
1Necrosis
01/2016
1Contusions
01/2015
1Cerebral Hemorrhage
12/2012
1Stroke (Strokes)
12/2012
1Sleep Wake Disorders
03/2012
1Ischemia
03/2010
1Embolism (Embolus)
03/2006
1Nervous System Trauma
03/2006
1Cerebral Infarction
10/2003
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2003

Drug/Important Bio-Agent (IBA)

17XenonIBA
11/2020 - 06/2002
10Neuroprotective AgentsIBA
11/2020 - 10/2003
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 03/2003
4DexmedetomidineFDA Link
01/2022 - 10/2004
3Zolpidem (Ambien)FDA LinkGeneric
01/2022 - 11/2016
3Oxygen (Dioxygen)IBA
11/2020 - 01/2005
3HeliumIBA
11/2019 - 02/2008
3Noble Gases (Rare Gases)IBA
11/2019 - 02/2008
3Pharmaceutical PreparationsIBA
01/2018 - 03/2012
3General AnestheticsIBA
10/2014 - 03/2010
3Anesthetics (Anesthetic Agents)IBA
11/2013 - 02/2011
2N-Methylaspartate (NMDA)IBA
01/2022 - 08/2005
2Glutamate Receptors (Glutamate Receptor)IBA
01/2022 - 08/2005
2ArgonIBA
11/2019 - 11/2013
2KryptonIBA
11/2019 - 11/2013
2Propidium (Propidium Iodide)IBA
01/2018 - 11/2013
2Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2013 - 03/2010
1Hypnotics and Sedatives (Sedatives)IBA
01/2022
1CalciumIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2021
1Valproic Acid (Depakote)FDA LinkGeneric
01/2021
1Sucrose (Saccharose)IBA
01/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/2021
1salicylhydroxamic acid (SHAM)IBA
11/2020
1NitrogenIBA
11/2020
1GasesIBA
11/2019
1GalaninIBA
10/2019
1Histamine (Histamine Dihydrochloride)FDA Link
01/2019
1Caspase 3 (Caspase-3)IBA
01/2018
1Explosive Agents (Explosives)IBA
01/2018
1Controlled SubstancesIBA
01/2018
1Glycine Receptors (Glycine Receptor)IBA
11/2016
1Propofol (Diprivan)FDA LinkGeneric
09/2012
1GABA-A Receptors (GABA(A) Receptor)IBA
03/2012
1Glucose (Dextrose)FDA LinkGeneric
08/2005
1Nitrous Oxide (Laughing Gas)IBA
01/2005
1Arachidonic Acid (Vitamin F)IBA
01/2005
1Halothane (Fluothane)FDA Link
01/2005
1RiluzoleFDA LinkGeneric
01/2005
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2005
1potassium channel protein TREK-1IBA
01/2005
1Potassium Channels (Potassium Channel)IBA
01/2005
1Excitatory Amino AcidsIBA
03/2003

Therapy/Procedure

3Therapeutics
01/2016 - 08/2005
1Neonatal Intensive Care
01/2016
1Resuscitation
01/2016
1Duration of Therapy
12/2012
1Treatment Delay
12/2012
1Ligation
12/2006
1Cardiopulmonary Bypass (Heart-Lung Bypass)
03/2003